Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2022 08:45 ET | Source: Love Pharma Inc.

Acquisition Has Love Pharma’s Naltrexone on NIH Shortlist to Address Unmet Medical Need—Treatment for Long Covid

NEW YORK, NY, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0), an international mental health and sexual wellness company, has been explicit about its plans to develop a...
September 08, 2022 08:30 ET | Source: Love Pharma Inc.

Love Pharma’s Investment in US Biotech Offers Strategic Industry Advantages and Enhanced Shareholder Value

NEW YORK, NY, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0), an international mental health and sexual wellness company, remains extremely active in shaping itself into...
November 30, 2021 08:50 ET | Source: Love Pharma Inc.

Love Pharma’s Acquisition Will Offer Exclusive Partnership and License with World Renowned University to Conduct Landmark Psilocybin Study

NEW YORK, NY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) continues to prioritize the necessity for clinical validation as a vital step in bringing its products to...
October 27, 2021 07:00 ET | Source: Love Pharma Inc.

LOVE Pharma Announces Debut of New Products, BLOOM™ and AURALIEF™

VANCOUVER, BC CANADA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- LOVE Pharma Co. (CSE: LUV) (FSE: G1Q0), the Company is pleased to announce the debut of its first two products, BLOOM™ and AURALIEF™. ...
October 04, 2021 08:45 ET | Source: Love Pharma Inc.

Love Pharma Makes Public Debut in Emerging Sexual Health, Wellness, and Psychedelics Markets

NEW YORK, NY, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV), formerly Glenbriar Technologies, Inc., is a new-age pharma/nutraceutical company that specializes in the global sexual...